Have a personal or library account? Click to login
Wistar rats with long-term streptozotocin-induced type 1 diabetes mellitus replicate the most relevant clinical, biochemical, and hematologic features of human diabetes / Sobolanii Wistar cu diabet zaharat tip 1 indus cu streptozotocina reproduc cele mai relevante caracteristici clinice, biochimice si hematologice ale diabetului uman Cover

Wistar rats with long-term streptozotocin-induced type 1 diabetes mellitus replicate the most relevant clinical, biochemical, and hematologic features of human diabetes / Sobolanii Wistar cu diabet zaharat tip 1 indus cu streptozotocina reproduc cele mai relevante caracteristici clinice, biochimice si hematologice ale diabetului uman

Open Access
|Sep 2015

References

  1. 1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010 Jan;87(1):4-14. DOI: 10.1016/j. diabres.2009.10.007
  2. 2. Green A, Patterson CC; EURODIAB TIGER Study Group. Europe and Diabetes. Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia. 2001 Oct;44(Suppl 3):B3-8. DOI: 10.1007/ PL0000295010.1007/PL00002950
  3. 3. Redondo MJ, Yu L, Hawa M, Mackenzie T, Pyke DA, Eisenbarth GS, et al. Heterogeneity of type I diabetes: Analysis of monozygotic twins in Great Britain and the United States. Diabetologia. 2001 Mar;44(3):354-62. DOI: 10.1007/s00125005162610.1007/s001250051626
  4. 4. Atkinson M, Eisenbarth G. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001 Jul;358(9277):221-9. DOI: 10.1016/S0140-6736(01)05415-010.1016/S0140-6736(01)05415-0
  5. 5. The Diabetes Prevention Trial-Type 1 Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med. 2002 May;346(22):1685-91. DOI: 10.1056/NEJMoa01235010.1056/NEJMoa01235012037147
  6. 6. Lenze S. The mechanisms of alloxan- and streptozotocin- induced diabetes. Diabetologia. 2008 Feb;51(2):216-26. DOI: 10.1007/s00125-007-0886-710.1007/s00125-007-0886-718087688
  7. 7. Wei M, Ong L, Smith MT, Ross FB, Schmid K, Hoey AJ, et al. The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes. Heart Lung Circ. 2003;12(1):44-50. DOI: 10.1046/j.1444-2892.2003.00160.x10.1046/j.1444-2892.2003.00160.x16352106
  8. 8. Bahey NG, Soliman GM, El-Deeb TA, El-Drieny EA. Influence of insulin and testosterone on diabetic rat ventral prostate: Histological, morphometric and immunohistochemical study. Journal of Microscopy and Ultrastructure. 2014;2(3):151-60. DOI: 10.1016/j. jmau.2014.06.002
  9. 9. Moorhead KT, Hill JV, Chase JG, Hann CE, Scotter JM, Storer MK, et al. Modelling acute renal failure using blood and breath biomarkers in rats. Comput Methods Programs Biomed. 2011 Feb;101(2):173-82. DOI: 10.1016/j.cmpb.2010.07.01010.1016/j.cmpb.2010.07.01020728235
  10. 10. Boroujeni NB, Hashemi SM, Khaki Z, Soleimani M. The reversal of hyperglycemia after transplantation of mouse embryonic stem cells induced into early hepatocyte- like cells in streptozotocin-induced diabetic mice. Tissue Cell. 2011 Apr;43(2):75-82. DOI: 10.1016/j. tice.2010.12.002
  11. 11. Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia. 2000 Dec;43(12):1528-33. DOI: 10.1007/ s00125005156410.1007/s00125005156411151762
  12. 12. Eleazu CO, Eleazu KC, Chukwuma S, Essien UN. Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans. J Diabetes Metab Disord. 2013 Dec;12(1):60. DOI: 10.1186/2251-6581-12-6010.1186/2251-6581-12-60796247424364898
  13. 13. Junod A, Lambert AE, Orci L, Pictet R, Gonet AE, Renold AE. Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med. 1967 Oct;126(1):201-5. DOI: 10.3181/00379727-126-3240110.3181/00379727-126-324014864021
  14. 14. Huang M, Gao L, Yang L, Lin F, Lei H. Abnormalities in the brain of streptozotocin-induced type 1 diabetic rats revealed by diffusion tensor imaging. Neuroimage Clin. 2012 Sep;1(1):57-65. DOI: 10.1016/j. nicl.2012.09.004
  15. 15. Ávila Dde L, Araújo GR, Silva M, Miranda PH, Diniz MF, Pedrosa ML, et al. Vildagliptin ameliorates oxidative stress and pancreatic beta cell destruction in type 1 diabetic rats. Arch Med Res. 2013 Apr;44(3):194-202. DOI: 10.1016/j.arcmed.2013.03.00410.1016/j.arcmed.2013.03.004
  16. 16. Yono M, Pouresmail M, Takahashi W, Flanagan JF, Weiss RM, Latifpour J. Effect of insulin treatment on tissue size of the genitourinary tract in BB rats with spontaneously developed and streptozotocin-induced diabetes. Naunyn Schmiedebergs Arch Pharmacol. 2005 Nov;372(3):251-5. DOI: 10.1007/s00210-005-0010-910.1007/s00210-005-0010-9
  17. 17. Groop PH, Thomas MC, Rosengård-Bärlund M, Mills V, Rönnback M, Thomas S, et al. HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes. Diabetes Care. 2007 Oct;30(10):2706-7. DOI: 10.2337/dc07-003010.2337/dc07-0030
  18. 18. Raghunathan S, Tank P, Bhadada S, Patel B. Evaluation of buspirone on streptozotocin induced type 1 diabetes and its associated complications. Biomed Res Int. 2014;2014:948427. DOI: 10.1155/2014/94842710.1155/2014/948427
  19. 19. Cameron NE, Cotter MA. Diabetes causes an early reduction in autonomic ganglion blood flow in rats. J Diab Complic. 2001 Jul-Aug;15(4):198-202. DOI: 10.1016/S1056-8727(01)00149-010.1016/S1056-8727(01)00149-0
  20. 20. Obrosova IG, Drel VR, Oltman CL, Mashtalir N, Tibrewala J, Groves JT, et al. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin- diabetic rats. Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1645-55. DOI: 10.1152/ajpendo.00479.200710.1152/ajpendo.00479.200717911342
  21. 21. Kiba T, Tanaka K, Numata K, Hoshino M, Misugi K, Inoue S. Ventromedial hypothalamic lesion-induced vagal hyperactivity stimulates rat pancreatic cell proliferation. Gastroenterology. 1996 Mar;110(3):885-93. DOI: 10.1053/gast.1996.v110.pm8608899 10.1053/gast.1996.v110.pm86088998608899
DOI: https://doi.org/10.1515/rrlm-2015-0028 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 263 - 274
Submitted on: Mar 12, 2015
Accepted on: Jun 26, 2015
Published on: Sep 30, 2015
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2015 Alina Scridon, Marcel Perian, Alina Marginean, Ciprian Fisca, Adriana Vantu, Doina Ghertescu, Philippe Chevalier, Razvan Constantin Serban, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.